SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Many of the difficulties in diagnosing choroidal melanomas which confronted clinicians in the past have now been eliminated. This is due to greater clinical awareness of melanomas and pseudomelanomas, as well as the use of indirect ophthalmoscopy and other ancillary tests. With further investigation, other diagnostic techniques may be developed for clinical use.
Explore the source record for details and available documents.
The retinoblastoma susceptibility gene, (RB), is a tumor suppressor gene which, when deleted is associated with the development of retinoblastoma. The observation that children with heritable retinoblastoma frequently develop second malignancies, principally sarcomas, led to the detection of similar RB gene deletions in some osteosarcomas. We studied 44 unselected sarcomas from patients with no antecedent retinoblastoma to determine the prevalence and nature of RB gene alterations. DNA and RNA were extracted from fresh tumors and analysed by Southern and Northern blotting. Three of nine osteosarcomas and 4 of 29 soft-tissue sarcomas had deletions of the RB gene. Four of these were full-length, and three were partial deletions of the gene. RNA from 5 of the 7 deleted tumors was studied, and 4 cases completely lacked the RB transcript. Transcripts were found in 19 of 20 tumors with an apparently intact RB gene, and in all the normal tissues studied. An additional tumor lacked the RB transcript, but the gene appeared intact at the DNA level. In total, 8 of 38 sarcomas were found to have alterations of the RB gene. These data indicate that the RB gene is inactivated in a significant number of sarcomas unrelated to retinoblastoma, and that the potential role for the gene in the pathogenesis of human malignancy may not be limited to retinoblastoma.
Human adenovirus groups A and B have an oncogenic potential in newborn rodents. Especially, adenovirus type 12 is known to induce retinoblastoma-like tumor in baboons and transform human embryo retinoblast cells in vitro. Human JC virus is also known to produce a variety of tumors in newborn rodents, including retinoblastoma-like tumor. In this experiment, cell DNAs of human retinoblastomas were assayed for each of the transforming gene sequences of adenovirus groups A, B, C, D and E and for JC virus gene sequences, by using Southern blot hybridization. None of these viral gene sequences were detected at the level of 0.1-0.5 copy per diploid cell DNA in all of 11 retinoblastomas, including 6 retinoblastomas previously examined for adenovirus 12-transforming gene sequences. This led to a conclusion that most, if not all, adenoviruses and JC virus play no essential role in the etiology of human retinoblastoma, although there were experimental models of retinoblastoma induced by these viruses.
Explore the source record for details and available documents.
Nine lung small-cell carcinoma (SCC) cell lines and 9 lung non-SCC cell lines were examined for structural changes of the retinoblastoma (RB) gene as well as its expression using a complementary DNA probe. The RB protein product was investigated using an anti-RB antibody which we produced. Although homozygosity or hemizygosity of the RB gene was suggested in 8 of 9 SCCs and one of 2 large cell carcinomas (LCCs) by Southern blot analysis using an RB cDNA probe and polymorphic DNA markers for chromosome 13, no obvious structural changes of the RB gene were detected in these 18 cell lines. However, RB transcripts were either markedly reduced in quantity or abnormal in length in 3 of 9 SCCs. The specific 115 kD protein was not immunoprecipitated by the anti-RB antibody in all 9 SCCs with either normal or abnormal size RB mRNA. Three of 4 adenocarcinomas (AdCs), all 3 squamous cell carcinomas, and one of 2 LCCs expressed normal size RB mRNA, and the 115 kD protein was immunoprecipitated by the anti-RB antibody. The 115 kD protein was also absent in one of 2 LCCs with shortened RB mRNA and in one of 4 AdCs with low level of RB mRNA expression. These results strongly suggest that inactivation of the RB gene might be involved in the development of lung cancers, especially of SCCs.
Explore the source record for details and available documents.
From 1957 to 1968, the 230-cm synchrocyclotron at the Gustaf Werner Institute was used for clinical tests with a 185 MeV proton beam. The radiotherapeutic research was part of an extensive research programme in physics, chemistry, biology and medicine. Only a small series of patients were treated. A brief review of the early development and clinical experience of the cyclotron activities at Uppsala from 1957 to 1968 is given. The former accelerator is now being converted. Beams are expected to be available in the new radiotherapy treatment rooms in 1986. Plans for the new facilities with special reference to alternative methods of proton acceleration and beam transport, i.e. fixed beams or an gantry system are presented. The corresponding activities at the Institute of Theoretical and Experimental Physics (ITEP) in Moscow are also referred to thanks to a bilateral research programme which has existed in the past and from which the Uppsala group has benefited greatly.
Explore the source record for details and available documents.
A case of a recurrent epibulbar naevus is presented; it underwent malignant transformation and subsequently invaded the eyeball. The tumour histologically was a predominantly epitheloid cell melanoma containing numerous histiocytes and degenerated tumour cells. Electron microscopy revealed rare special structures, e.g. annulated lamellae, tubuloreticular structures, pseudocrystals in huge mitochondria. Besides, invasion of tumour cells into a capillary could be shown.
This study identifies the presence of major histocompatibility complex class II antigens on retinoblastoma cells. In addition, the modulation of HLA-DR by interferon-gamma as well as the preferential expression of this major histocompatibility complex molecule over HLA-DQ is described. Double labeling experiments revealed that HLA-DR antigen is shared concomitantly with cells of glial and neuronal character. Investigations such as these underscore the possibility that expression of major histocompatibility complex class II antigens may function as immunological components in the host or play a role in the cellular differentiation of these tumor cells.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A pilot study was performed to test for melanoma-associated antigens (MAAgs) in the sera of patients with localized uveal melanoma, using monoclonal antibodies (MoAbs). Both whole sera and polyethylene glycol (PEG) 2.5% serum precipitates from 18 patients with clinically localized uveal melanoma and two patients with localized invasive conjuctival melanoma were analyzed for two human cutaneous MAAgs by an enzyme-linked immunosorbent assay (ELISA). These antigens could not be identified when whole sera were used. However, after PEG precipitation, a MoAb specific for the p210 MAAg reacted with four of 20 patient samples and none of 17 controls. A second MoAb specific for the p97a MAAg reacted with one of 20 patients and none of 17 controls. These findings indicate the existence of antigens common to both uveal and cutaneous melanoma and suggest that the refinement of assays to screen sera with a battey of MoAbs may be of value in diagnosing and/or monitoring patients with uveal melanoma. Circulating immune complexes were detected in the sera of six patients but did not correlate with any clinical features or with the presence or absence of detectable MAAgs.
Explore the source record for details and available documents.